Traders should watch for downward pressure on VERA shares and monitor upcoming filings for any changes in guidance, clinical trial updates, or financing activities. The coordinated nature of these sales by top executives may signal lack of confidence in near-term prospects despite no public negative news.
Price Chart
Executive Summary
Seven executives at Vera Therapeutics, including the CEO, CFO, and other C-suite officers, collectively sold over $1.4 million in shares on February 23, 2026, in coordinated open-market transactions at approximately $42 per share. This represents a significant insider selling cluster involving nearly the entire executive leadership team.
Key Financial Metrics
Key Facts
- CEO Marshall Fordyce sold 16,925 shares for $710,577, the largest individual transaction.
- All seven transactions were open-market sales (Form 4 code 'S') executed on the same day at the same price ($41.9839).
- Total value of the cluster: $1,406,042.71 across 33,490 shares.
- Sellers include CMO, CFO, COO, CCO, CAO, CRO, and CEO — all key executives with direct insight into company performance.
- No purchases or non-cash transactions (e.g., grants, exercises) were part of this cluster.
Financial Impact
$1.41 million in insider selling over a single day
Risk Factors
- Potential perception of insider pessimism ahead of upcoming clinical or financial results.
- Increased selling pressure if additional insiders follow suit or if the company announces equity financing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (7 trades, 7d window) | cluster-VERA-1772103657760 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 8-K | $33.67 $34.00 | ▲ +0.98% | ▲ +0.16% | $30.13 (−10.53%) |
Aug 10, 2026 7w ago | 8-K | $30.29 $32.28 | ▲ +6.57% | ▲ +6.97% | $30.13 (−0.54%) |
Aug 10, 2026 7w ago | Press Release | $30.29 $32.28 | ▲ +6.57% | ▲ +6.97% | $30.13 (−0.54%) |
Jul 9, 2026 12w ago | 8-K | $42.45 $39.12 | ▼ −7.84% | ▼ −7.71% | $30.13 (−29.03%) |
Jul 7, 2026 12w ago | 8-K | $42.96 $43.13 | ▲ +0.40% | ▼ −0.16% | $30.13 (−29.88%) |
Jun 11, 2026 16w ago | Institutional Cluster | $33.65 $35.01 | ▲ +4.04% | ▲ +3.61% | $30.13 (−10.48%) |
Jun 2, 2026 17w ago | 8-K | $31.26 $31.81 | ▲ +1.76% | ▲ +4.72% | $30.13 (−3.63%) |
Jun 2, 2026 17w ago | Press Release | $31.26 $31.81 | ▲ +1.76% | ▲ +4.72% | $30.13 (−3.63%) |
May 7, 2026 21w ago | 8-K | $35.88 $39.15 | ▲ +9.11% | ▲ +7.61% | $30.13 (−16.04%) |
Feb 26, 2026 31w ago | 8-K | $42.35 $38.85 | ▼ −8.26% | ▼ −7.14% | $30.13 (−28.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access